Steven Cohen’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$579K Buy
+1,100
New +$617K ﹤0.01% 3111
2025
Q4
Sell
-4,400
Closed -$2.81M 4019
2025
Q3
$2.81M Hold
4,400
﹤0.01% 1306
2025
Q2
$2.36M Hold
4,400
﹤0.01% 1233
2025
Q1
$1.85M Buy
4,400
+500
+13% +$217K ﹤0.01% 1268
2024
Q4
$1.61M Buy
+3,900
New +$1.71M ﹤0.01% 1319
2024
Q3
Sell
-3,100
Closed -$1.51M 2157
2024
Q2
$1.51M Buy
+3,100
New +$1.56M ﹤0.01% 1172
2022
Q3
Sell
-18,000
Closed -$6.31M 1537
2022
Q2
$6.31M Buy
+18,000
New +$7.34M 0.03% 641

Other funds holding IDXX

Steven Cohen's IDXX Position: Q2 2026 in Review

Steven Cohen increased its Idexx Laboratories (IDXX) stake by 103% in Q2 2026, buying an estimated $74.9M and bringing the position to 262,905 shares worth $138M. The position accounts for 0.15% of the portfolio, ranked #133.

Steven Cohen first reported a position in IDXX in Q1 2015 and has held it in 17 quarters since. 1,293 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • Steven Cohen held 262,905 shares of Idexx Laboratories worth $138M as of Q2 2026.
  • Steven Cohen bought 133,621 Idexx Laboratories shares in Q2 2026, an estimated $74.9M.
  • Idexx Laboratories made up 0.15% of Steven Cohen's portfolio in Q2 2026, its #133 holding.
  • Steven Cohen first reported a position in Idexx Laboratories in Q1 2015 and has held it in 17 quarters since.
  • 1,293 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Point72 Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.